[
  {
    "ts": null,
    "headline": "3 Mid-Cap Stocks to Research Further",
    "summary": "Large trillion-dollar companies are tightening their grip on the market, often by acquiring smaller rivals. This trend will likely pick up with new regulatory leadership, but a few mid-sized businesses will continue prospering by anchoring themselves in unique market segments.",
    "url": "https://finnhub.io/api/news?id=454959fae4c8926060c6bfc351a2905e53b01d87440baf04146b52046e3ffb2d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764822876,
      "headline": "3 Mid-Cap Stocks to Research Further",
      "id": 137680384,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "Large trillion-dollar companies are tightening their grip on the market, often by acquiring smaller rivals. This trend will likely pick up with new regulatory leadership, but a few mid-sized businesses will continue prospering by anchoring themselves in unique market segments.",
      "url": "https://finnhub.io/api/news?id=454959fae4c8926060c6bfc351a2905e53b01d87440baf04146b52046e3ffb2d"
    }
  },
  {
    "ts": null,
    "headline": "Humana (HUM): Revisiting Valuation After Volatile Returns and Ongoing Medicare Advantage Uncertainty",
    "summary": "Humana (HUM) has been on a choppy path lately, with the stock slipping over the past 3 months even as profits grow. That gap between earnings momentum and price is what matters now. See our latest analysis for Humana. Over the past year, Humana’s share price has been volatile, with a modest year to date share price return of 1.7 percent but a steeper 3 year total shareholder return of negative 51.8 percent, pointing to fading longer term momentum despite the recent rebound. If Humana’s swings...",
    "url": "https://finnhub.io/api/news?id=1d3fcbbf4b4bbe5c62e7668c21366af0f811cb434d32a3fe21b135701239eb43",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764814233,
      "headline": "Humana (HUM): Revisiting Valuation After Volatile Returns and Ongoing Medicare Advantage Uncertainty",
      "id": 137678262,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "Humana (HUM) has been on a choppy path lately, with the stock slipping over the past 3 months even as profits grow. That gap between earnings momentum and price is what matters now. See our latest analysis for Humana. Over the past year, Humana’s share price has been volatile, with a modest year to date share price return of 1.7 percent but a steeper 3 year total shareholder return of negative 51.8 percent, pointing to fading longer term momentum despite the recent rebound. If Humana’s swings...",
      "url": "https://finnhub.io/api/news?id=1d3fcbbf4b4bbe5c62e7668c21366af0f811cb434d32a3fe21b135701239eb43"
    }
  }
]